Profile
Frank M.
Longo is the founder of PharmatrophiX, Inc., which was founded in 2005.
He holds the title of Chairman at PharmatrophiX, Inc. Dr. Longo is currently working at Stanford University, where he has been Chairman-Neurology & Neurological Sciences since 2006.
In terms of education, Dr. Longo obtained a doctorate degree from the University of California San Diego in 1981 and another doctorate degree in 1983.
He also has a graduate degree from Harvard T.H.
Chan School of Public Health.
Frank M. Longo active positions
| Companies | Position | Start |
|---|---|---|
PharmatrophiX, Inc.
 PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Founder | 2004-12-31 |
| Stanford University | Corporate Officer/Principal | 2005-12-31 |
Training of Frank M. Longo
| University of California San Diego | Doctorate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
PharmatrophiX, Inc.
PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Health Technology |
- Stock Market
- Insiders
- Frank M. Longo